Ignite Creation Date:
2024-05-06 @ 9:00 AM
Last Modification Date:
2024-10-26 @ 12:08 PM
Study NCT ID:
NCT02873975
Status:
COMPLETED
Last Update Posted:
2022-10-21
First Post:
2016-08-17
Brief Title:
A Study of LY2606368 Prexasertib in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Cancers |
Keywords:
| Name | View |
|---|---|
| Fanconi anemia | View |
| Advanced Cancers | View |
| Solid tumors | View |
| MYC amplification | View |
| CCNE1 amplification | View |
| Rb loss | View |
| FBXW7 mutation | View |
| BRCA1 mutation | View |
| BRCA2 mutation | View |
| PALB2 mutation | View |
| RAD51C mutation | View |
| RAD51D mutation | View |
| ATR mutation | View |
| ATM mutation | View |
| CHK2 mutation | View |